Real-time enrollment status for this her2-positive breast cancer clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 3:55 AM UTC
| NCT Number | NCT07413939 |
| Recruiting Status | Recruiting |
| Condition | HER2-positive Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 650 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | August 5, 2026 (4 weeks ago) |
As of September 2, 2026: Clinical trial NCT07413939 is currently recruiting participants. This phase2 study for her2-positive breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07413939 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07413939 was last updated 4 weeks ago (August 5, 2026). HelloStudys verifies this status automatically.